EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lectin-Based Substrate Detection in Fabry Disease Using the Gb3-Binding Lectins StxB and LecA

Serap Elçin-Guinot, Simon Lagies iD, Yoav Avi-Guy iD, Daniela Neugebauer iD, Tobias B Huber, Christoph Schell, Bernd Kammerer, Winfried Römer iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26052272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Serap Elçin-Guinot und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, University of Freiburg, Schänzlestraße 1, 79104 Freiburg, Germany. Hauptthemen laut MEDLINE: Fabry Disease, Trihexosylceramides, Lectins, Shiga Toxin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Ministry of Science, Research and the Arts of the State of Baden-Württemberg, German Research Foundation (DFG) under Germany’s Excellence Strategy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fabry disease, the second most common lysosomal storage disorder, is caused by a deficiency of α-galactosidase A (α-Gal A), which leads to an accumulation of glycosphingolipids (GSL), mainly globotriaosylceramide (also known as Gb3). This aberrant GSL metabolism subsequently causes cellular dysfunction; however, the underlying cellular and molecular mechanisms are still unknown. There is growing evidence that damage to organelles, including lysosomes, mitochondria, and plasma membranes, is associated with substrate accumulation. Current methods for the detection of Gb3 are based on anti-Gb3 antibodies, the specificity and sensitivity of which are problematic for glycan detection. This study presents a robust method using lectins, specifically the B-subunit of Shiga toxin (StxB) from Shigella dysenteriae and LecA from Pseudomonas aeruginosa, as alternatives for Gb3 detection in Fabry fibroblasts by flow cytometry and confocal microscopy. StxB and LecA showed superior sensitivity, specificity, and consistency in different cell types compared to all anti-Gb3 antibodies used in this study. In addition, sphingolipid metabolism was analyzed in primary Fabry fibroblasts and α-Gal A knockout podocytes using targeted tandem liquid chromatography-mass spectrometry. Our findings establish lectins as a robust tool for improved diagnostics and research of Fabry disease and provide evidence of SL changes in cultured human cells, filling a knowledge gap.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry DiseaseTrihexosylceramidesLectinsShiga ToxinHumansalpha-GalactosidaseFibroblastsGlycosphingolipidsSphingolipids

Stichwörter der Autor:innen

GLA-knockout human podocytesGb3LecAStxBanti-Gb3 antibodyglycosphingolipidslectinslyso-Gb3lysosomal storage disorderpatient-derived Fabry fibroblasts

Substanzen

Trihexosylceramidesglobotriaosylceramidealpha-GalactosidaseLectinsShiga ToxinGlycosphingolipidsSphingolipids

Autor:innen und Institutionen

  • Faculty of Biology, University of Freiburg, Schänzlestraße 1, 79104 Freiburg, Germany.
  • BIOSS, Centre for Biological Signaling Studies, University of Freiburg, Schänzlestraße 18, 79104 Freiburg, Germany.
  • CIBSS, Centre for Integrative Biological Signaling Studies, University of Freiburg, Schänzlestraße 18, 79104 Freiburg, Germany.
  • Core Competence Metabolomics, Hilde-Mangold-Haus, University of Freiburg, Habsburgerstraße 19, 79104 Freiburg, Germany.
  • Institute of Organic Chemistry, University of Freiburg, Albertstraße 19, 79104 Freiburg, Germany.
  • III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246 Hamburg, Germany.

ORCID-Profile: Simon Lagies, Yoav Avi-Guy, Daniela Neugebauer, Winfried Römer

Förderung

  • Deutsche Forschungsgemeinschaft
  • Ministry of Science, Research and the Arts of the State of Baden-Württemberg
  • German Research Foundation (DFG) under Germany’s Excellence Strategy
  • DFG
  • RTG 2202
  • German Research Foundation
  • Heisenberg program

Zitieren

APA

Elçin-Guinot, S., Lagies, S., Avi-Guy, Y., Neugebauer, D., Huber, T. B., Schell, C., Kammerer, B., & Römer, W. (2025). Lectin-Based Substrate Detection in Fabry Disease Using the Gb3-Binding Lectins StxB and LecA. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052272

Vancouver

Elçin-Guinot S, Lagies S, Avi-Guy Y, Neugebauer D, Huber TB, Schell C, et al. Lectin-Based Substrate Detection in Fabry Disease Using the Gb3-Binding Lectins StxB and LecA. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052272

BibTeX
@article{ElinGuinot2025,
  author = {Elçin-Guinot, Serap and Lagies, Simon and Avi-Guy, Yoav and Neugebauer, Daniela and Huber, Tobias B and Schell, Christoph and Kammerer, Bernd and Römer, Winfried},
  title = {Lectin-Based Substrate Detection in Fabry Disease Using the Gb3-Binding Lectins StxB and LecA},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26052272}
}
Kostenlos starten →